Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT01915134 · UNKNOWN

Trial details

NCT number: NCT01915134
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Effects of Chemotherapy Stage IVC Nasopharyngeal Carcinoma

Start date: 2013-08-01
Primary completion: 2016-01-01
Enrollment: 362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.